At a glance
ClinicalIndex Comparison RecordN/ACompleted· 102 enrolled
Drug / intervention
esomeprazole+amox+levo +1 moredrug
Likely dose
esomeprazole+amox+levo 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment
In Brief
A clinical study evaluating esomeprazole+amox+levo and esomeprazole+bismuth+tetra+levo for Helicobacter Pylori Infection. Completed, enrolled 102 participants across 1 site.
Detailed Summary
From the profiles of antibiotic susceptibility data following eradication therapy, tetracycline, amoxicillin and levofloxacin are all good candidates of antibiotics used in the rescue treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHelicobacter Pylori Infection
CountriesTaiwan
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
First PostedNov 2016
Primary CompletionSep 2017
TodayJul 2026
First PostedNov 30, 2016
Enrollment StartFeb 1, 2015
Primary CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 9.6 years ago
Interventions
esomeprazole+amox+levodrug
esomeprazole 40 mg b.d., amoxicillin 500 mg q.d.s., levofloxacin 500 mg o.d.
esomeprazole+bismuth+tetra+levodrug
esomeprazole 40 mg b.d., bismuth 120 mg q.d.s., tetracycline 500 mg q.d.s., and levofloxacin 500 mg o.d.